Thus, though a few studies reported no relationship between urine/serum CXCL8 and renal function in patients with T1D and microalbuminuria (137–140), there is substantial evidence warranting further exploration of the potential clinical benefit of CXCR1/2 inhibition in diabetic nephropathy. The gene discussed is CXCR1; the disease is type 1 diabetes mellitus.